Malaysia to study findings on AstraZeneca-blood clots link before use, says Khairy


Malaysia has procured 6.4 million doses, or two jabs each of the AstraZeneca Covid vaccine for 3.2 million people. – EPA pic, April 8, 2021.

MALAYSIA will study the findings of the European Medicines Agency (EMA) on a possible link between the  AztraZeneca vaccine and blood clots before deciding to use the the Covid-19 shots, Khairy Jamaluddin said. 

The national immunisation programme coordinator said the special committee on Covid-19 vaccine supply (JKJAV) will study the matter.


Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!



Sign up or sign in here to comment.


Comments